WeVote

Bill

Bill

HD 2992

An Act to improve warning labels on THC products

194th Legislature (2025-2026) Introduced by Marcus Vaughn

Massachusetts bill requiring clearer THC product labels with potency information and health warnings to inform consumers and reduce unintended overconsumption risks.

Senate concurred
0
WeVote Research Nonpartisan
Bill Summary · HD 2992

Legislative bill overview

HD 2992 would mandate improved warning labels on tetrahydrocannabinol (THC) products sold in Massachusetts. The bill requires clearer, more prominent labeling of THC content, potency information, and health warnings on cannabis products. This applies to all THC products sold through licensed dispensaries in the state.

Why is this important

Clearer labeling helps consumers make informed purchasing decisions and understand product strength, which is particularly significant as THC potency in modern cannabis products has increased substantially over the past decade. Improved warnings may reduce accidental overconsumption, especially among inexperienced users and populations vulnerable to adverse effects (youth, pregnant individuals, those with mental health conditions). This also addresses public health concerns about the rise of high-potency concentrate products.

Potential points of contention

  • Industry compliance costs: Cannabis retailers argue that redesigning packaging and labels creates significant expenses, potentially passed to consumers through higher prices
  • Label effectiveness debate: Critics question whether warning labels significantly change consumer behavior, citing studies on tobacco and alcohol showing limited impact on usage patterns
  • Standardization challenges: Determining what constitutes "improved" warnings and whether state-level standards conflict with federal guidance remains contentious, as does defining appropriate warning language that doesn't exaggerate risks

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.